The Hotamışlıgil Lab at the Sabri Ülker Center studies innate adaptive pathways involved in metabolic health and diseases such as obesity, diabetes, and cardiovascular disease. Using biochemical, genetic, and physiological studies, we aim to find novel pathways and preventive, therapeutic solutions to today’s greatest threats to global human health.
The Harvard Chan Research Center on Causes and Prevention of Cardiovascular Disease (CAP-CVD) studies the metabolic risk factors of cardiovascular disease. We operate through action-oriented research collaborations between basic, clinical, and population-based scientists. Our goals are to uncover the metabolic risk landscape of cardiovascular disease, and to translate this knowledge into prevention and treatment options within the next ten years.